Our Residents and Faculty
We'd like to introduce you to our residency family. We believe in creating a warm, respectful learning environment, and intentionally cultivate our community to be supportive and welcoming. While the clinical training here is top-notch, we think you'll find that the quality of the people is even better. Click the images below for brief biographies of each of our doctors.
Class of 2021
Class of 2020
Class of 2019
- David Araujo, M.D.
- Leslie-Lynn Pawson, M.D.
- Cheryl Lambing, M.D.
- Kristi Schoeld, M.D.
- Neil Jorgensen, M.D.
- Jim Helmer, M.D.
- Sheri Dickstein, M.D.
- Jacob David, M.D.
- Zach Zwolak, D.O.
- Wally Baker, M.D.
- Daniel Cox, M.D., M.S.
- Ian Wallace, M.D.
- Dorothy DeGuzman, M.D., M.P.H.
- Tipu V. Khan, M.D., FAAFP
- Ron Bale, Ph.D.
Diagnosis and Management of Acute Otitis Media
The diagnosis of acute otitis media requires one of the following findings:
- moderate to severe bulging of the tympanic membrane
- new ottorhea (that is not due to acute otitis externa)
- mild bulging of the TM and recent (less than 48 hours) onset of ear pain or intense erythema of the TM.
Antibiotics should be given in one of the following settings
- AOM (as above) with severe signs/symptoms (moderate/severe ear pain, ear pain for >48 hours, temperature >102.2 °F)
- Bilateral AOM in children > 6 months but <2 years of age
If AOM is diagnosed but the patient does not meet the criteria above, choose one of the following options based on clinical judgement and discussion with patient:
- prescribe antibiotics
- observe with close follow-up (with a mechanism to prescribe antibiotics if the patient worsens or fails to improve within 2-3 days)
Choice of antibiotics:
- Amoxicillin is first-line
Choose an alternative to amoxicillin if
- child has recieved amoxicillin in past month
- concurrent purulent conjunctivitis
- allergy to penicillin
- history of AOM unresponsive to amoxicillin
The 2013 ASCVD Cholesterol Guidelines for dyslipidemia management by the ACC and AHA suggest a significant practice change.
Basically, statins are indicated for the four following groups:
- Patients with any form of clinical ASCVD
- Patients with primary LDL-C levels of 190 mg per dL or greater
- Patients with diabetes mellitus, 40 to 75 years of age, with LDL-C levels of 70 to 189 mg per dL
- Patients without diabetes, 40 to 75 years of age, with an estimated 10-year ASCVD risk ≥ 7.5%
Here's the ASCVD Risk Calculator:
The WHO Fracture Risk Assessment Tool can help guide your management of osteoporosis. By estimating 10-year probability of fracture, you can have an informed conversation with your patient about bisphosphonate therapy.